Geode Capital Management, LLC Immunome Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,860,580 shares of IMNM stock, worth $31.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,860,580

Previous 1,743,057 6.74%

Holding current value

$31.1 Million

Previous $11.7 Million 47.51%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$5.56 - $9.79 $653,427 - $1.15 Million	117,523 Added 6.74%	1,860,580 $17.3 Million
Q1 2025 May 13, 2025	BUY	$6.73 - $11.83 $3.46 Million - $6.08 Million	514,206 Added 41.84%	1,743,057 $11.7 Million
Q4 2024 Feb 12, 2025	BUY	$9.11 - $14.53 $194,917 - $310,883	21,396 Added 1.77%	1,228,851 $12.6 Million
Q3 2024 Nov 12, 2024	BUY	$11.7 - $16.51 $1.69 Million - $2.39 Million	144,557 Added 13.6%	1,207,455 $17.7 Million
Q2 2024 Aug 09, 2024	BUY	$11.54 - $22.11 $7.28 Million - $13.9 Million	630,419 Added 145.77%	1,062,898 $12.9 Million
Q1 2024 May 13, 2024	BUY	$11.01 - $27.34 $1.23 Million - $3.05 Million	111,641 Added 34.8%	432,479 $10.7 Million
Q4 2023 Feb 13, 2024	BUY	$7.3 - $10.73 $1.72 Million - $2.53 Million	236,130 Added 278.76%	320,838 $3.43 Million
Q3 2023 Nov 13, 2023	BUY	$6.17 - $9.16 $21,564 - $32,014	3,495 Added 4.3%	84,708 $707,000
Q4 2022 Feb 13, 2023	SELL	$2.21 - $5.0 $426 - $965	-193 Reduced 0.24%	81,213 $178,000
Q1 2022 May 13, 2022	BUY	$3.88 - $13.99 $5,579 - $20,117	1,438 Added 1.8%	81,406 $462,000
Q4 2021 Feb 11, 2022	BUY	$12.96 - $23.44 $327,875 - $593,008	25,299 Added 46.28%	79,968 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$12.5 - $27.76 $189,250 - $420,286	15,140 Added 38.3%	54,669 $1.33 Million
Q2 2021 Aug 13, 2021	SELL	$16.33 - $32.33 $160,066 - $316,898	-9,802 Reduced 19.87%	39,529 $683,000
Q1 2021 May 12, 2021	BUY	$9.56 - $43.24 $326,483 - $1.48 Million	34,151 Added 224.97%	49,331 $1.67 Million
Q4 2020 Feb 12, 2021	BUY	$9.46 - $14.16 $143,602 - $214,948	15,180 New	15,180 $146,000

Others Institutions Holding IMNM

# of Institutions

147

Shares Held

66.6M

Call Options Held

44.9K

Put Options Held

4.24M

View Full List

About Immunome Inc.

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $203M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

More about IMNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Immunome Inc. Transaction History